Glutathione S-transferase P1 (GSTP1) polymorphism in patients with chronic obstructive pulmonary disease

Thorax

Volumn 54, Issue 8, 1999, Pages 693-696

  Ishii, T ^a   Matsuse, T ^a   Teramoto, S ^a   Matsui, H ^a   Miyao, M ^a   Hosoi, T ^a   Takahashi, H ^b   Fukuchi, Y ^b   Ouchi, Y ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic obstructive pulmonary disease; Glutathione S transferase P1 (GSTP1); Polymorphism; Tobacco

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DNA; GLUTATHIONE TRANSFERASE; METHYLXANTHINE; TOBACCO SMOKE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; GENOTYPE; HOMOZYGOTE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0032800636     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.54.8.693     Document Type: Article

References (26)

1. 1 Siafakas NM, Vermeire P, Pride NB, et al on behalf of the Task Force. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995;8:1398-420.
2. 2 Murray CJL, Lopez AD. Evidence-based health policy lessons from the Global Burden of Disease study. Science 1996;274:740-3.
3. 3 Robin ED. Summary: symposium on pulmonary emphysema and proteolysis. In: Mittman C, ed. Pulmonary emphysema and proteolysis.. New York: Academic Press, 1972: 527-37.
4. 4 Church DF, Pryor WA. Free radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 1985;64:111-26.
5. 5 Carp H, Miller F, Hoidal JR, et al. Potential mechanism of emphysema: alpha 1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc Natl Acad Sci USA 1982;79:2041-5.
6. 6 Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977;1:1645-8.
7. 7 Bascom R. Differential susceptibility to tobacco smoke: possible mechanisms. Pharmacogenetics 1991;1:102-6.
8. 8 Silverman EK, Chapman HA, Drazen JM, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 1998;157:1770-8.
9. 9 Mannervik B. The isozymes of glutathione S-transferase. Adv Enzymol 1985;57:357-417.
10. 10 Harrison DJ, Cantly AM, Rae F, et al. Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer. Hum Exp Toxicol 1997;17:356-60.
11. 11 Board PG, Webb GC, Coggan M. Isolation of a cDNA clonc and localization of the human glutathione S-transferase 3 genes to chromosome bands 11q13 and 12q13-14. Ann Hum Genet 1989;53:205-13.
12. 12 Johansson AS, Stenberg G, Widersten M, et al. Structure-activity relationships and thermal stability of human glutathione transferase PI-1 governed by the H-site residue 105. J Mol Biol 1998;278:687-98.
13. 13 Ryberg D, Skaug V, Hewer A, et al. Genotypes of glutathione transferase MI and PI and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 1997;18:1285-9.
14. 14 Sundberg K, Johansson AS, Stenberg G, et al. Differences in the catalytic efficiencies of allelic variants of glutathione transferase PI-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998;19: 433-6.
15. 15 Cantlay AM, Smith CA, Wallace WA, et al. Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax 1994;49:1010-4.
16. 16 Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8:1398-420.
17. 17 Fletcher CM, Pride NB. Definition of emphysema, chronic bronchitis, asthma, and airflow obstruction: 25 years on from the Ciba symposium. Thorax 1984; 39:81-5.
18. 18 Watson MA, Stewart RK, Smith GBJ, et al. Human glutathione S-transferase PI polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 1998; 19:275-80.
19. 19 Cantlay AM, Lamb D, Gillooly M, et al. Association between the CYPIA1 gene polymorphism and susceptibility to emphysema and lung cancer. J Clin Mol Pathol 1995; 48;M210-4.
20. 20 Smith CAD, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997;350:630-3.
21. 21 Huang S-L, Su C-H, Chang S-C. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 1997;156:1436-9.
22. 22 Hurst R, Bao Y, Jemth P, et al. Phospholipid hydroperoxide glutathione peroxidase activity of human glutathione transferases. Biochem J 1998;332:97-100.
23. 23 Hoffmann D, Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health 1997;50:307-64.
24. 24 Chen H, Juchau MR. Inhibition of embryonic retinoic acid synthesis by aldehydes of lipid peroxidation and prevention of inhibition by reduced glutathione and glutathione S-transferases. Free Radic Biol Med 1998;24:408-17.
25. 25 Massaro GD, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema. Nature Med 1997;3:675-7.
26. 26 Lo HW, Ali-Osman F. Genomic cloning of hGSTP1C and allelic human pi class glutathione S-transferase gene variant and functional characterization of its retinoic acid response elements. J Biol Chem 1997;272:32743-9.